CRC
EBS icon

Curi RMB Capital’s Emergent Biosolutions EBS Stock Holding History

Curi RMB Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-136,093
Closed -$4.47M – 573
2016
Q4 		$4.47M Buy
136,093
+1,587
+1% +$47.6K 0.24% 125
2016
Q3 		$4.24M Buy
134,506
+26,929
+25% +$782K 0.23% 119
2016
Q2 		$3.02M Sell
107,577
-22,095
-17% -$866K 0.16% 136
2016
Q1 		$4.71M Buy
129,672
+12,764
+11% +$451K 0.31% 99
2015
Q4 		$4.68M Buy
116,908
+528
+0.5% +$18.4K 0.22% 102
2015
Q3 		$3.32M Buy
116,380
+8,235
+8% +$271K 0.22% 112
2015
Q2 		$3.56M Sell
108,145
-26,497
-20% -$821K 0.23% 104
2015
Q1 		$3.87M Sell
134,642
-31,271
-19% -$897K 0.23% 109
2014
Q4 		$4.52M Sell
165,913
-12,291
-7% -$293K 0.28% 89
2014
Q3 		$3.8M Buy
178,204
+2,752
+2% +$63K 0.23% 106
2014
Q2 		$3.94M Buy
175,452
+42,199
+32% +$983K 0.25% 90
2014
Q1 		$3.37M Sell
133,253
-1,288
-1% -$32.5K 0.23% 102
2013
Q4 		$3.09M Buy
134,541
+41,578
+45% +$867K 0.21% 106
2013
Q3 		$1.77M Buy
+92,963
New +$1.66M 0.13% 184

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Curi RMB Capital's EBS Position: Q1 2017 in Review

Curi RMB Capital sold out of Emergent Biosolutions (EBS) in Q1 2017, closing a stake of 136,093 shares — an estimated $4.47M sold.

Curi RMB Capital first reported a position in EBS in Q3 2013 and held it in 14 quarters. The position peaked at $4.71M in Q1 2016. 176 funds tracked by Wall St. Rank hold EBS as of Q1 2017.

  • Curi RMB Capital reported no remaining Emergent Biosolutions position as of Q1 2017 after selling out during the quarter.
  • Curi RMB Capital sold 136,093 Emergent Biosolutions shares in Q1 2017, an estimated $4.47M.
  • Curi RMB Capital first reported a position in Emergent Biosolutions in Q3 2013 and held it in 14 quarters.
  • Curi RMB Capital's Emergent Biosolutions position peaked at $4.71M in Q1 2016.
  • 176 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2017.

Based on Curi RMB Capital's 13F filing for Q1 2017, filed 12 May 2017.